Relying on the in‑depth understanding of industry policies and regulations from our shareholders,partners and the team,together with their expertise and resource strengths in registration,clinical research and regulatory review,we fully leverage the comprehensive efficiency and cost‑competitiveness of domestic pharmaceutical R&D,We develop innovative,advanced‑technology products that are globally aligned or even world‑leading to address unmet medical needs for patients across the globe.

Focus on the development of first-in-class molecular entities for global advanced therapeutic products,innovative targets and/or mechanisms,as well as fast-follow,best-in-class innovative molecular entities for validated targets and/or mechanisms.